| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/12/2008 | CA2487331C Anti-inflammatory compositions and methods of use |
| 08/12/2008 | CA2420461C Preparations for oral administration |
| 08/12/2008 | CA2408887C Medical composition kit for treating lesioned abnormal tissue |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/12/2008 | CA2376236C Modification of biological elements |
| 08/12/2008 | CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 08/12/2008 | CA2315721C Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine |
| 08/12/2008 | CA2253238C Novel agouti-related gene |
| 08/12/2008 | CA2217551C Photoactivated hypericin and the use thereof |
| 08/12/2008 | CA2135787C Polypeptide bombesin antagonists |
| 08/07/2008 | WO2008094976A2 Use of estrogen receptor beta selective ligands for treating acute lung injuries |
| 08/07/2008 | WO2008094061A1 Pharmaceutical and cosmetic compositions for accelerated healing of wounds and other surface damages |
| 08/07/2008 | WO2008093855A1 Composition for treatment of undifferentiated-type of gastric cancer |
| 08/07/2008 | WO2008093826A1 Adiponectin-increasing agent |
| 08/07/2008 | WO2008093737A1 Amide derivative |
| 08/07/2008 | WO2008093700A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound |
| 08/07/2008 | WO2008093691A1 Protective agent for retinal nerve or optic nerve |
| 08/07/2008 | WO2008093686A1 Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof |
| 08/07/2008 | WO2008093678A1 Hyaluronidase inhibitor |
| 08/07/2008 | WO2008093655A1 Polyalcohol compound and pharmaceutical agent |
| 08/07/2008 | WO2008093646A1 Peptide capable of activating wnt signaling |
| 08/07/2008 | WO2008093639A1 Pyrazole compound |
| 08/07/2008 | WO2008093614A1 Novel hepatitis c virus inhibitor |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008092924A1 Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk] [1] -benzazepin-2 [1h] -one and zilpaterol |
| 08/07/2008 | WO2008092862A1 Bicyclic derivatives as ep4 agonists |
| 08/07/2008 | WO2008092861A1 Bicyclic derivatives as ep4 agonists |
| 08/07/2008 | WO2008092860A1 Bicyclic derivatives as ep4 agonists |
| 08/07/2008 | WO2008092681A1 Ghrelin receptor modulators |
| 08/07/2008 | WO2008074267A3 Liposomal gel phthalocyanine preparation for photodynamic therapy of tumors and its manufacturing |
| 08/07/2008 | WO2007149000A3 New structural protein preparations |
| 08/07/2008 | WO2007137181A3 Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation |
| 08/07/2008 | US20080188817 Stable Liquid IL-1 Antagonist Formulations |
| 08/07/2008 | US20080188548 Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof |
| 08/07/2008 | US20080188546 Preventive or therapeutic agents for decubitus |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188519 Novel azacyclic ethynyl derivatives |
| 08/07/2008 | US20080188507 3-(3-biphenylyl)-5-[3-oxospiro[6-azaisobenzofuran-1(3H),4'-piperidin]-1'-yl]-1H-pyrazole; neuropeptide Y receptor antagonists; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188451 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia) |
| 08/07/2008 | US20080188430 RNA interference mediated inhibition of hypoxia inducible factor 1 (HIF1) gene expression using short interfering nucleic acid (siNA) |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188415 Composition of matter containing harmonized hydroxyl modified fullerene substance |
| 08/07/2008 | US20080188412 Anticancer agent screening; contacting in vitro with BH4 domain peptide and/or mimetic to inhibit union with FK-binding protein 38; overcoming drug resistant strains |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187994 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; immunotherapy |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187581 Solid dosage form; active materials and solid on substrate |
| 08/07/2008 | US20080187573 Pharmaceutical composition formulated for pre-gastric absorption of monoamine oxidase b inhibitor component |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187547 Immune receptor translocation associated-5 (IRTA-5 ) protein specific immunoglobulin for use in diagnosis, prevention and treatment of B cell malignancies |
| 08/07/2008 | US20080187541 Helicobacter pylori adhesin binding group antigen |
| 08/07/2008 | US20080187538 Posh nucleic acids, polypeptides and related methods |
| 08/07/2008 | US20080187537 Using immunodeficient animals to generate cancer cell infiltrating lymphocytes; immunotherapy; tissue targeted therapy |
| 08/07/2008 | US20080187533 Treatment with anti-erbb2 antibodies |
| 08/07/2008 | US20080187532 Compositions and methods for diagnosing and treating cancer |
| 08/07/2008 | US20080187529 Anti-human vegf receptor flt-1 monoclonal antibody |
| 08/07/2008 | US20080187523 Nucleotide sequences coding genetically engineered zinc finger protein for use in treatment and prevention of cell proliferative disorders |
| 08/07/2008 | US20080187518 Production of Osteoclasts from Adipose Tissues |
| 08/07/2008 | US20080187514 Using hematopoietic stem cells to restore functional and structural integrity to damaged myocardium; tissue engineering; tissue repair; regenerative medicine |
| 08/07/2008 | US20080187510 Methods for Improving Drug Disposition |
| 08/07/2008 | US20080187493 Peptide-Based Compounds |
| 08/07/2008 | US20080187488 Phage antibodies to radiation-inducible neoantigens |
| 08/07/2008 | DE10132669B4 Pharmakologische Zubereitung aus einem nanopartikulären mesomorphen Polyelektrolyt-Lipid-Komplex und mindestens einem Wirkstoff Pharmacological preparation of a nanoparticulate mesomorphic polyelectrolyte-lipid complex and at least one active ingredient |
| 08/07/2008 | CA2676796A1 Composition for treatment of undifferentiated gastric cancer |
| 08/07/2008 | CA2676553A1 Use of er.beta. selective ligands for treating acute lung injuries |
| 08/06/2008 | EP1953173A1 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
| 08/06/2008 | EP1953148A1 Heterocyclic amide compound and use thereof |
| 08/06/2008 | EP1953142A1 Process for the preparation of antihistaminic 4-diphenylmethyl piperidine derivatives |
| 08/06/2008 | EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 08/06/2008 | EP1952818A1 Inhibitor of osteoclast formation, composition for oral administration and prophylactic or therapeutic agent for bone disease comprising lactoferrin-containing liposome |
| 08/06/2008 | EP1952700A1 Method of improving absorption of vitamin E by a pet animal |
| 08/06/2008 | EP1951225A2 3-acylindole derivatives the preparation and the therapeutic use thereof |
| 08/06/2008 | EP1951224A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 08/06/2008 | EP1951220A2 Compositions for lowering serum cholesterol and/or triglycerides |
| 08/06/2008 | EP1951186A2 Methods for the treatment of hyperhidrosis |
| 08/06/2008 | EP1811839A4 Methods and compositions related to esculentoside a |
| 08/06/2008 | EP1569596B1 A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis |
| 08/06/2008 | EP1485088B1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds |
| 08/06/2008 | EP1476149B1 Substituted hydrazones as inhibitors of cyclooxygenase-2 |
| 08/06/2008 | EP1474144B1 Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor |
| 08/06/2008 | EP1432714B1 Chemical compounds |
| 08/06/2008 | EP1377671B1 Oncolytic adenoviral vectors |
| 08/06/2008 | EP1363875B1 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1236712B1 Amidinophenylpyruvic acid derivative |
| 08/06/2008 | EP1205185B1 Uterine contraction inhibitors |
| 08/06/2008 | EP1147133B1 Peptides consisting of two PTH functional domains fused by a linker molecule, and derivatives thereof |
| 08/06/2008 | EP1127168B1 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 08/06/2008 | EP1042467B1 Non-identical genes and their application in improved molecular adjuvants |
| 08/06/2008 | EP1023447B1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 08/06/2008 | EP1015884B1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 08/06/2008 | CN101237885A Agent for regeneration and/or protection of nerves |
| 08/06/2008 | CN101237869A Pyridone derivatives for modulating stress-activated protein kinase system |
| 08/06/2008 | CN101235030A 1-substituted-5-trifluoromethyl-2-(1H)pyridone compound, preparation method and use thereof |
| 08/06/2008 | CN101235004A Omega-amidosulphonic acid substituted hypocrellin derivatives, preparation method and application thereof |
| 08/06/2008 | CN101234126A Collagen peptide of Jellyfish with anti-fatigue active and preparation technique thereof |
| 08/06/2008 | CN101234109A Pharmaceutical composition containing (3R, 2í»S)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |